NOVEL PROCESS FOR THE PREPARATION OF SUVOREXANT
ABSTRACT
The present invention is to provide a novel and cost-effective process for the preparation of Suvorexant with high purity and that will be suitable for industrially large-scale preparation.
[Class : 5] Medicinal And Pharmaceutical Preparations Included In Class 05.
View +15 more Brands for Jupiter Pharmaceuticals Ltd.
Charges
6 Crore
11 April 2015
Axis Bank Limited
3 Crore
27 November 2012
Axis Bank Limited
2 Crore
27 June 2007
Ge Capital Transportation Financial Services Ltd
5 Lak
02 April 2004
State Bank Of India
48 Lak
17 January 2002
State Bank Of India
1 Crore
27 October 2006
State Bank Of India
1 Crore
28 April 1999
West Bengal Financial Corporation
24 Lak
28 April 1999
West Bengal Financial Corporation
50 Lak
24 February 2022
Axis Bank Limited
0
11 April 2015
Axis Bank Limited
0
27 June 2007
Ge Capital Transportation Financial Services Ltd
0
27 October 2006
State Bank Of India
0
27 November 2012
Axis Bank Limited
0
02 April 2004
State Bank Of India
0
28 April 1999
West Bengal Financial Corporation
0
17 January 2002
State Bank Of India
0
28 April 1999
West Bengal Financial Corporation
0
24 February 2022
Axis Bank Limited
0
11 April 2015
Axis Bank Limited
0
27 June 2007
Ge Capital Transportation Financial Services Ltd
0
27 October 2006
State Bank Of India
0
27 November 2012
Axis Bank Limited
0
02 April 2004
State Bank Of India
0
28 April 1999
West Bengal Financial Corporation
0
17 January 2002
State Bank Of India
0
28 April 1999
West Bengal Financial Corporation
0
24 February 2022
Axis Bank Limited
0
11 April 2015
Axis Bank Limited
0
27 June 2007
Ge Capital Transportation Financial Services Ltd
0
27 October 2006
State Bank Of India
0
27 November 2012
Axis Bank Limited
0
02 April 2004
State Bank Of India
0
28 April 1999
West Bengal Financial Corporation
0
17 January 2002
State Bank Of India
0
28 April 1999
West Bengal Financial Corporation
0
Documents
Form DPT-3-04042021_signed
Form CHG-1-01012021_signed
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20201231
Instrument(s) of creation or modification of charge;-31122020
Form MGT-14-27082020_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-26082020
Form AOC - 4 CFS-21112019_signed
Form DPT-3-20112019-signed
Consolidated Financial statements duly authenticated as per section 134 (Including Boards report, auditors report and other docu-20112019
Supplementary or Test audit report under section 143-20112019
Form AOC-4-10112019_signed
Form MGT-7-08112019_signed
List of share holders, debenture holders;-07112019
Directors report as per section 134(3)-24102019
Details of salient features and justifications for entering into Contracts/Arrangements/Transactions with related parties as per section 188 (1) - Form AOC - 2-24102019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-24102019
Form CHG-1-20042019_signed
Instrument(s) of creation or modification of charge;-20042019
CERTIFICATE OF REGISTRATION FOR MODIFICATION OF CHARGE-20190420
Form MGT-14-30032019_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-30032019
List of share holders, debenture holders;-16112018
Form MGT-7-16112018_signed
Consolidated Financial statements duly authenticated as per section 134 (Including Boards report, auditors report and other docu-12112018
Supplementary or Test audit report under section 143-12112018
Form AOC - 4 CFS-12112018_signed
Details of salient features and justifications for entering into Contracts/Arrangements/Transactions with related parties as per section 188 (1) - Form AOC - 2-25102018